The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Gilead Sciences; Janssen; Merck; Pfizer
Speakers' Bureau - Celgene; Gilead Sciences; Janssen; Merck; Pfizer
Low-dose cytarabine with or without glasdegib in newly diagnosed patients with acute myeloid leukemia: Long-term analysis of a phase 2 randomized trial.
 
B. Douglas Smith
Honoraria - Celgene; Jazz Pharmaceuticals; Novartis Pharmaceuticals UK Ltd.; Pfizer
Consulting or Advisory Role - Celgene; CSL Behring; Pfizer
 
Cristina Papayannidis
Honoraria - Novartis
Consulting or Advisory Role - Amgen; Teva
Travel, Accommodations, Expenses - Janssen; Pfizer; Shire
 
Michael Heuser
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Janssen Oncology; Novartis; Pfizer; Stemline Therapeutics
Research Funding - Astellas Pharma (Inst); Bayer (Inst); BerGenBio (Inst); Daiichi Sankyo (Inst); Novartis (Inst); Pfizer (Inst)
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Mikkael A. Sekeres
Consulting or Advisory Role - Celgene; Millennium; Syros Pharmaceuticals
Research Funding - Pfizer (Inst); Takeda (Inst)
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene; Janssen
 
Gary J. Schiller
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer (Inst)
 
Anna Candoni
No Relationships to Disclose
 
Catriona HM Jamieson
No Relationships to Disclose
 
Caroline J. Hoang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Wendy Ma
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Mirjana Zeremski
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ashleigh O'Connell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Geoffrey Chan
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Takeda
Research Funding - Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Immunogen (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)